Studies on the in vivo and in vitro estrogenic activities of methoxychlor and its metabolites. Role of hepatic mono-oxygenase in methoxychlor activation

https://doi.org/10.1016/0006-2952(78)90354-4Get rights and content

Abstract

The injection of rats with methoxychlor stimulated uterine ornithine decarboxylase (ODC) activity and caused an increase in uterine weight 7 hr after injection. The di-demethylated derivative of methoxychlor {[2,2-bis(p-hydroxyphenyl-1,1,1-trichloroethane] (HPTE)} markedly stimulated rat uterine ODC and enlarged uterine wet weight 6 hr after administration. Because we previously demonstrated that HPTE, but not methoxychlor, inhibited the binding of [3H]estradiol-17β ([3H]E2) to uterine cytosolic estrogen receptor in vitro, we considered the possibility that the estrogenic activity of methoxychlor in vivo was due to biotransformation of methoxychlor. The evolution of formaldehyde occurred when methoxychlor was incubated with rat hepatic microsomes in the presence of NADPH, indicating that methoxychlor was O- demethylated in vitro. The demethylation of methoxychlor was inhibited when methoxychlor was incubated with microsomes in the presence of hexobarbital or 2-diethylaminoethyl diphenyl-propylacetate hydrochloride (SKF-525A), suggesting the involvement of mono-oxygenase. Furthermore, the demethylated products were resolved by thin-layer chromatography (t.l.c.) into three chromatographically distinct components more polar than methoxychlor. One of the products appears to be the di-demethylated derivative of methoxychlor, since it was chromatographically identical to HPTE in three t.l.c. systems. Each of the three components inhibited [3H]E2 binding to rat uterine cytosol in vitro; however, the metabolite with an Rf equal to that of HPTE demonstrated equal potency to HPTE with respect to suppression of [3H]E2 binding to uterine cytosol. The possible involvement of mono-oxygenase in biotransformation in methoxychlor into estrogenic metabolites in vivo is discussed.

References (34)

  • W.H. Bulger et al.

    J. Toxic. Envir. Hlth

    (1978)
  • J.A. Nelson et al.

    Pharmacologist

    (1976)
  • A. Raina et al.

    Med. Biol.

    (1975)
  • Y. Kobayashi et al.

    Science, N.Y.

    (1971)
  • S.H. Burstein et al.

    Ann. N.Y. Acad. Sci.

    (1971)
  • A.L. Fisher et al.
  • P.J. Bunyan et al.

    Chem. Biol. Interact

    (1972)
  • D. Kupfer et al.

    Drug. Metab. Dispos.

    (1973)
  • R.L. MetcalfR.L. Metcalf
  • L.Y. Gibney

    Chem. Eng. News

    (1975)
  • W.J. HayesW.J. Hayes
  • F.M. Kunze et al.
  • J.H. Weikel

    Archs Int. Pharmacodyn. Thér.

    (1957)
  • I.P. Kapoor et al.

    J. agric. Fd Chem.

    (1970)
  • D. Kupfer

    CRC Crit. Rev. Toxic.

    (1975)
  • D. Kupfer et al.
  • J. Bitman et al.

    J. agric. Fd Chem.

    (1970)
  • Cited by (231)

    • Endocrine disrupting potential of selected azole and organophosphorus pesticide products through suppressing the dimerization of human androgen receptor in genomic pathway

      2022, Ecotoxicology and Environmental Safety
      Citation Excerpt :

      Several pesticide containing organochlorides were shown to behave as EDCs via interference with endogenous hormone synthesis and degradation (Warner et al., 2020). For example, the estrogenic effect of DDT was first reported in 1952, and that of the insecticides, kepone and methoxychlor, was reported in the 1970 s (Fisher et al., 1952; Gellert, 1978; Bulger et al., 1978). Also, Ostby et al. (1999) reported that linuron and vinclozolin showed anti-androgenic effects.

    • Mass spectrometric determination of N7-HPTE-dG and N7-HPTE-Gua in mammalian cells and mice exposed to methoxychlor, an emergent persistent organic pollutant

      2022, Journal of Hazardous Materials
      Citation Excerpt :

      Armenti et al. also displayed that female Fischer rats exposed to MXC resulted in irregular estrous cyclicity and reduced ovulation (Armenti et al., 2008). One primary mechanism for MXC’s reprotoxicity is the estrogenic and anti-estrogenic activity of MXC and its metabolites (Bulger et al., 1978; Ousterhout et al., 1981). CYP450s were involved in the metabolically activation of enormous pollutants (Gao et al., 2018).

    • A case study on the application of an expert-driven read-across approach in support of quantitative risk assessment of p,p’-dichlorodiphenyldichloroethane

      2019, Regulatory Toxicology and Pharmacology
      Citation Excerpt :

      The major metabolic pathway for methoxychlor in mice involves sequential demethylation at its p-positions (O-demethylation) yielding mono- and bis-hydroxy methoxychlor derivatives that are preferentially excreted via the feces (Table 3). These demethylated metabolites possess greater endocrine disrupting activity compared to methoxychlor (Bulger et al., 1978; Charles et al., 2000; Maness et al., 1998; Sumida et al., 2001) and are likely to be involved in the reproductive effects of the parent chemical; thus, metabolic activation of methoxychlor is expected through this pathway. Aliphatic dechlorination represents a minor oxidation pathway for methoxychlor that produces metabolites such as bis-hydroxydiphenyl acetic acid, bis-hydroxybenzophenone, and bis-hydroxy-dichloroethylene (Table 3).

    • Toxicology Assessment of Endocrine-Active Substances

      2018, Comprehensive Toxicology: Third Edition
    • Environmental Issues in Maintaining Reproductive Health

      2018, Bioenvironmental Issues Affecting Men's Reproductive and Sexual Health
    View all citing articles on Scopus

    Part of this work was presented at the meeting of the American Society for Pharmacology and Experimental Therapeutics, August 21–25, 1977, Ohio State University, Columbus, OH [Pharmacologist19 (2), abstr. 411].

    View full text